Trial intelligence / Profile preview

Preoperative mitomycin C in primary urothelial carcinoma

2015-003680-11Phase 4Active

Sponsor
Presurgy
Start
Nov 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of mitomycin c in transitional cell carcinoma (TCC), sponsored by Presurgy. Started Nov 2015; status: active.

02

Drugs

mitomycin c
03

Conditions

transitional cell carcinoma (TCC)

Beyond the preview

Go deeper on 2015-003680-11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-003680-11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call